Strategic Medical Communications for Biotech & Diagnostics
Helping biotech and scientific teams interpret complex science and translate It into credible publications, evidence, and positioning.
Core Areas of Engagements
Publications & Evidence Development
Manuscripts, narrative reviews, and evidence synthesis that strengthen scientific credibility and support strategic positioning.
Strategic Medical Communications
Scientific framing and message frameworks that align research, medical, and commercial stakeholders.
Advisory & Embedded Scientific Support
Senior scientific input to clarify interpretation, reduce iteration cycles, and align cross-functional decision-making.
Who I work With
Early- to mid-stage biotech and diagnostics companies
Medical communications agencies seeking senior scientific support
Teams working with complex or novel modalities, including NGS and neuroscience
When to bring me in
I am most valuable in providing structured scientific judgment, particularly when ambiguity is high, stakes are material, and positioning will soon face external scrutiny. This can include:
First or early publications
Emerging competitive landscape
Non-dilutive grant strategy
Advisory board preparation
Fundraising and investor-facing preparation
Market access and clinical utility positioning
How Engagements Are Structured
1. Alignment
Define scientific objectives, audience, and strategic constraints.
Claim boundaries are clarified early through a structured defensibility lens focused on:
Biological plausibility
Clinical signal robustness
Comparative differentiation
Implementation feasibility
2. Development
Develop and refine materials through structured interrogation and pressure-testing of assumptions and interpretive boundaries, minimizing downstream revision and reducing internal decision friction.
3. Delivery
Deliver materials that are not only publication- or stakeholder-ready, but calibrated for external scrutiny and long-term credibility.